Dashboard
Manage Tickers

EVOKEvoke Pharma Inc

Nasdaq evokepharma.com


$ 0.47 $ 0.00 (-0.32 %)    

Wednesday, 15-May-2024 15:51:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 452.83 $ 6.97 (1.56 %)
DIA $ 399.31 $ 3.70 (0.94 %)
SPY $ 529.09 $ 6.48 (1.24 %)
TLT $ 92.14 $ 1.24 (1.36 %)
GLD $ 220.89 $ 2.80 (1.28 %)
$ 0.4685
$ 0.47
$ 0.00 x 0
$ 0.00 x 0
$ 0.47 - $ 0.47
$ 0.41 - $ 2.16
47,318
na
4.25M
$ 0.72
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 03-14-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-21-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-10-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-08-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-12-2021 03-31-2021 10-Q
14 03-11-2021 12-31-2020 10-K
15 11-10-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-12-2020 03-31-2020 10-Q
18 03-12-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 03-06-2019 12-31-2018 10-K
23 11-13-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-14-2018 03-31-2018 10-Q
26 03-07-2018 12-31-2017 10-K
27 11-14-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 05-15-2017 03-31-2017 10-Q
30 03-15-2017 12-31-2016 10-K
31 11-09-2016 09-30-2016 10-Q
32 08-15-2016 06-30-2016 10-Q
33 05-11-2016 03-31-2016 10-Q
34 03-10-2016 12-31-2015 10-K
35 11-12-2015 09-30-2015 10-Q
36 08-13-2015 06-30-2015 10-Q
37 05-14-2015 03-31-2015 10-Q
38 03-04-2015 12-31-2014 10-K
39 11-13-2014 09-30-2014 10-Q
40 08-13-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

evoke-pharma-reiterates-fy24-net-revenue-14m-vs-14081-est
Evoke Pharma Reiterates FY24 Net Revenue ~...
05/14/2024 20:55:35

evoke-pharma-q1-2024-gaap-eps-017-beats-021-estimate-sales-174m-miss-214m-estimate
Evoke Pharma Q1 2024 GAAP EPS $(0.17) Beat...
05/14/2024 20:54:31

Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.21) ...

evoke-pharma-announces-senior-leadership-transition-with-promotion-of-matthew-j-donofrio-to-chief-executive-officer-as-of-march-31-2024
Evoke Pharma Announces Senior Leadership T...
03/21/2024 20:28:34

Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) ...

evoke-pharma-sees-fy24-net-revenue-14m-vs-14017m-est
Evoke Pharma Sees FY24 Net Revenue ~$14M V...
03/14/2024 20:50:06

recap-evoke-pharma-q4-earnings
Recap: Evoke Pharma Q4 Earnings
03/14/2024 20:35:20

evoke-pharma-q4-2023-gaap-eps-059-misses-050-estimate-sales-1676m-beat-1632m-estimate
Evoke Pharma Q4 2023 GAAP EPS $(0.59) Miss...
03/14/2024 20:31:03

Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.50...

earnings-scheduled-for-march-14-2024
Earnings Scheduled For March 14, 2024
03/14/2024 09:52:13

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
03/13/2024 21:32:47

laurence-w-lytton-reports-in-13g-filing-a-999-stake-in-evoke-pharma
Laurence W. Lytton Reports In 13G Filing A...
03/13/2024 18:02:17

https://www.sec.gov/Archives/edgar/data/1105806/000093583624000282/evok13g.htm

a-preview-of-evoke-pharmas-earnings
A Preview Of Evoke Pharma's Earnings
03/13/2024 18:02:17

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
02/09/2024 13:06:11

evoke-pharma-has-priced-an-underwritten-public-offering-led-by-nantahala-capital-management-for-gross-proceeds-of-up-to-30m-million-which-includes-initial-upfront-funding-of-approximately-75m
Evoke Pharma Has Priced An Underwritten Pu...
02/09/2024 12:33:00

The offering is comprised of (i) 11,029,411 shares of common stock (or pre-funded warrants in lieu thereof), (ii) 11,029,411 Se...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
01/23/2024 17:31:00

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
01/16/2024 21:31:08

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
01/15/2024 13:05:45

why-wipro-shares-are-trading-higher-by-over-16-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Wipro Shares Are Trading Higher By Ove...
01/12/2024 18:28:33

Shares of Wipro Limited (NYSE: WIT) rose sharply during Friday’s session after the company reported third-quarter financial res...

why-vci-global-shares-are-trading-lower-by-around-30-here-are-20-stocks-moving-premarket
Why VCI Global Shares Are Trading Lower By...
01/12/2024 12:52:45

Shares of VCI Global Limited (NASDAQ: VCIG) fell sharply in pre-market trading after the company announced pricing of $2.75 mi...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
01/11/2024 21:31:17

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
01/11/2024 17:31:07

evoke-pharma-announces-fda-orange-book-listing-of-new-gimoti-patent
Evoke Pharma Announces FDA Orange Book Lis...
11/27/2023 13:31:55

Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION